[Economic evaluation of combined therapy in chronic hepatitis C].
Casado
M A
MA
Schering-Plough, S.A. Paseo de la Castellana, 143, 28046 Madrid.
Buti
M
M
Fosbrook
L
L
Esteban
R
R
D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D004359:Drug Therapy, Combination; D017850:Economics, Pharmaceutical; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D007372:Interferons / Q000191:economics / Q000627:therapeutic use; D008017:Life Expectancy
D000998:Antiviral Agents; D007372:Interferons